The health ministers of six South American countries gathered in Buenos Aires, Argentina, on Wednesday to “coordinate defenses against” the H1N1 (swine flu) virus which has killed nearly 200 people in the region,” the AFP/Google.com reports.
Also In Global Health News: Disease-Specific Initiatives; Polio In Pakistan; Mental Illness; Rep. Payne Interview
Disease-Specific Initiatives Produce Mixed Results, Survey Says Disease-specific initiatives, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and PEPFAR, are having mixed results on health systems in recipient countries and should be “retooled to become less disruptive,” according to a survey conducted by the NGO Groots Kenya…
“The first clinical trial of an HIV/AIDS vaccine designed and developed in South Africa was launched in Cape Town” Monday, the SAPA/The Times reports.
The following articles look at how countries are combating H1N1 (swine flu): NPR’s Morning Edition examines the “complicated” task ahead to administer two vaccines â€“ one that offers protection against the seasonal flu, the other protecting against the H1N1 (swine flu) virus â€“ to the public this fall (Knox, 7/20).…
An experimental malaria vaccine created by “an approach pioneered more than 30 years ago but abandoned as wildly impractical” is about to be tested on humans, the Seattle Times reports.
The worldwide death toll from the H1N1 (swine flu) virus has doubled in the past month, reaching over 700, the WHO announced Tuesday, the AP/Google.com reports.
IAS Conference: Low-Cost CD4 Tests; HIV Prevalence Among Pregnant Zimbabweans; Treating HIV-TB With ARVs; Vaccine Trials
The following are stories fromÂ this week’sÂ 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa: SciDev.Net: Steven ReidÂ of theÂ Imperial College London spoke of three prototype tests he and his colleagues have been working on that would help to increase access to CD4…
Lancet Commends U.K. All-Parliamentary Group on AIDS Call For HIV Drug Patent Pool A Lancet editorial examines recent recommendations by the U.K. All-Parliamentary Group on AIDS for pharmaceutical companies to implement an HIV drug patent pool â€“ an appeal, “Drug companies have dismissed” in the past. The authors conclude, “Although…
“Global health officials are scrambling to try to prevent the spread of the H1N1 swine flu virus, with U.S. officials moving Thursday with a recommendation that the Food and Drug Administration approve or license a [new H1N1] vaccine,” without waiting on the results from “clinical trials to test its safety and efficacy,” Wall Street Journal reports (Dooren/Winning, 7/24).
The race to develop a H1N1 (swine flu) vaccine before the fall flu season ramped up Wednesday, after Australia launched the first human trials of the H1N1 vaccine and scientists from the U.S., China and Britain announced plans for human trials of an H1N1 vaccine in the coming weeks, AFP/France24.com reports.